J. L. Goldstein and M. S. Brown, The LDL receptor, Arterioscler Thromb Vasc Biol, vol.29, issue.4, pp.431-439, 2009.

B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, L. Masana et al., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, vol.34, issue.45, pp.3478-90, 2013.

B. Lefort, S. Saheb, E. Bruckert, C. Giraud, O. Hequet et al., Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia, Atherosclerosis, vol.239, issue.1, pp.158-62, 2015.

M. Cuchel, E. Bruckert, H. N. Ginsberg, F. J. Raal, R. D. Santos et al., Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society, Eur Heart J, vol.35, issue.32, pp.2146-57, 2014.

M. A. Cayo, J. Cai, A. Delaforest, F. K. Noto, M. Nagaoka et al., JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia, Hepatology, vol.56, issue.6, pp.2163-71, 2012.

F. Fattahi, S. Asgari, B. Pournasr, A. Seifinejad, M. Totonchi et al., Disease-corrected hepatocyte-like cells from familial hypercholesterolemiainduced pluripotent stem cells, Mol Biotechnol, vol.54, issue.3, pp.863-73, 2013.

V. M. Ramakrishnan, J. Y. Yang, K. T. Tien, T. R. Mckinley, B. R. Bocard et al., Restoration of physiologically responsive low-density lipoprotein receptormediated endocytosis in genetically deficient induced pluripotent stem cells, Sci Rep, vol.5, p.13231, 2015.

S. T. Rashid, S. Corbineau, N. Hannan, S. J. Marciniak, E. Miranda et al., Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J Clin Invest, vol.120, issue.9, pp.3127-3163, 2010.

A. Ghodsizadeh, A. Taei, M. Totonchi, A. Seifinejad, H. Gourabi et al., Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells, Stem Cell Rev, vol.6, issue.4, pp.622-654, 2010.

F. P. Pankowicz, K. E. Jarrett, W. R. Lagor, and K. D. Bissig, CRISPR/Cas9: at the cutting edge of hepatology, Gut, vol.66, issue.7, pp.1329-1369, 2017.

K. E. Jarrett, C. M. Lee, Y. H. Yeh, R. H. Hsu, R. Gupta et al., Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease, Sci Rep, vol.7, p.44624, 2017.

R. N. Aravalli and C. J. Steer, CRISPR/Cas9 therapeutics for liver diseases, J Cell Biochem, vol.119, issue.6, pp.4265-78, 2018.

D. C. Luther, Y. W. Lee, H. Nagaraj, F. Scaletti, and V. M. Rotello, Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges, Expert Opin Drug Deliv, vol.15, issue.9, pp.905-918, 2018.

M. Sadelain, E. P. Papapetrou, and F. D. Bushman, Safe harbours for the integration of new DNA in the human genome, Nat Rev Cancer, vol.12, issue.1, pp.51-59, 2011.

S. Molina, V. Castet, C. Fournier-wirth, L. Pichard-garcia, R. Avner et al., The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus, J Hepatol, vol.46, issue.3, pp.411-420, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00374413

A. Albecka, S. Belouzard, A. Op-de-beeck, V. Descamps, L. Goueslain et al., Role of low-density lipoprotein receptor in the hepatitis C virus life cycle, Hepatology, vol.55, issue.4, pp.998-1007, 2012.

D. J. Felmlee, M. L. Hafirassou, M. Lefevre, T. F. Baumert, and C. Schuster, Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease, Viruses, vol.5, issue.5, pp.1292-324, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00850889

T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto et al., Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nat Med, vol.11, issue.7, pp.791-797, 2005.

P. Podevin, A. Carpentier, V. Pene, L. Aoudjehane, M. Carriere et al., Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes, Gastroenterology, vol.139, issue.4, pp.1355-64, 2010.

A. Carpentier, A. Tesfaye, V. Chu, I. Nimgaonkar, F. Zhang et al., Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model, J Clin Invest, vol.124, issue.11, pp.4953-64, 2014.

K. Okita, Y. Matsumura, Y. Sato, A. Okada, A. Morizane et al., A more efficient method to generate integration-free human iPS cells, Nat Methods, vol.8, issue.5, pp.409-421, 2011.

P. Mali, L. Yang, K. M. Esvelt, J. Aach, M. Guell et al., RNA-guided human genome engineering via Cas9, Science, vol.339, issue.6121, pp.823-829, 2013.

N. Dianat, H. Dubois-pot-schneider, C. Steichen, C. Desterke, P. Leclerc et al., Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells, Hepatology, vol.60, issue.2, pp.700-714, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01169803

F. Beilstein, M. Lemasson, V. Pene, D. Rainteau, S. Demignot et al., Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: impact on production of lipo-viro-particles, Gut, vol.66, issue.12, pp.2160-2169, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01366451

M. Carriere, V. Pene, A. Breiman, F. Conti, S. Chouzenoux et al., A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication, J Med Virol, vol.79, issue.2, pp.155-60, 2007.

S. Laperche, F. Bouchardeau, V. Thibault, B. Pozzetto, S. Vallet et al., Multicenter trials need to use the same assay for hepatitis C virus viral load determination, J Clin Microbiol, vol.45, issue.11, pp.3788-90, 2007.

V. Pene, C. Hernandez, C. Vauloup-fellous, J. Garaud-aunis, and A. R. Rosenberg, Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment, J Viral Hepat, vol.16, issue.10, pp.705-720, 2009.

M. Baxter, S. Withey, S. Harrison, C. P. Segeritz, F. Zhang et al., Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, issue.3, pp.581-590, 2015.

K. Cameron, R. Tan, W. Schmidt-heck, G. Campos, M. J. Lyall et al., Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes, Stem Cell Rep, vol.5, issue.6, pp.1250-62, 2015.

L. Tolosa, J. Caron, Z. Hannoun, A. M. Lopez, S. Burks et al., Transplantation of hESC-derived hepatocytes protects mice from liver injury, Stem Cell Res Ther, vol.6, p.246, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01254139

T. Touboul, S. Chen, C. C. To, S. Mora-castilla, K. Sabatini et al., Stagespecific regulation of the WNT/beta-catenin pathway enhances differentiation of hESCs into hepatocytes, J Hepatol, vol.64, issue.6, pp.1315-1341, 2016.

J. Qin, M. Chang, S. Wang, Z. Liu, W. Zhu et al., Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells, Sci Rep, vol.6, p.37388, 2016.

D. K. Spady, S. D. Turley, and J. M. Dietschy, Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences, J Clin Invest, vol.76, issue.3, pp.1113-1135, 1985.

M. Abifadel, M. Varret, J. P. Rabes, D. Allard, K. Ouguerram et al., Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, vol.34, issue.2, pp.154-160, 2003.

H. Y. Kan, P. Pissios, J. Chambaz, and V. I. Zannis, DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter, Nucleic Acids Res, vol.27, issue.4, pp.1104-1121, 1999.

T. A. Lagace, PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells, Curr Opin Lipidol, vol.25, issue.5, pp.387-93, 2014.

L. Omer, E. A. Hudson, S. Zheng, J. B. Hoying, Y. Shan et al., CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells, Hepatol Commun, vol.1, issue.9, pp.886-98, 2017.

J. R. Smith, S. Maguire, L. A. Davis, A. M. Yang, F. Chandran et al., Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration, Stem Cells, vol.26, issue.2, pp.496-504, 2008.

L. Ordovas, R. Boon, M. Pistoni, Y. Chen, E. Wolfs et al., Efficient recombinasemediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition, Stem Cell Rep, vol.5, issue.5, pp.918-949, 2015.

D. Castro-oros, I. Pampin, S. Bolado-carrancio, A. , D. Cubas et al., Functional analysis of LDLR promoter and 5? UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia, Hum Mutat, vol.32, issue.8, pp.868-72, 2011.

I. Dagher, T. H. Nguyen, M. T. Groyer-picard, P. Lainas, S. Mainot et al., Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates, Hepatology, vol.49, issue.3, pp.950-959, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00326130

G. F. Codner, J. Mianne, A. Caulder, J. Loeffler, R. Fell et al., Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants, BMC Biol, vol.16, issue.1, p.70, 2018.

J. Latimer, J. A. Batty, R. D. Neely, and V. Kunadian, PCSK9 inhibitors in the prevention of cardiovascular disease, J Thromb Thrombolysis, vol.42, issue.3, pp.405-424, 2016.

V. Charlton-menys and P. N. Durrington, Human cholesterol metabolism and therapeutic molecules, Exp Physiol, vol.93, issue.1, pp.27-42, 2008.

J. Yang, Y. Wang, T. Zhou, L. Y. Wong, X. Y. Tian et al., Generation of human liver chimeric mice with hepatocytes from familial hypercholesterolemia induced pluripotent stem cells, Stem Cell Rep, vol.8, issue.3, pp.605-623, 2017.

S. Belouzard, A. Danneels, L. Feneant, K. Seron, Y. Rouille et al., Entry and release of hepatitis C virus in polarized human hepatocytes, J Virol, vol.91, issue.18, pp.478-495, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02104456

D. M. Owen, H. Huang, J. Ye, and M. Gale, Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor, Virology, vol.394, issue.1, pp.99-108, 2009.

S. Yamamoto, T. Fukuhara, C. Ono, K. Uemura, Y. Kawachi et al., Lipoprotein receptors redundantly participate in entry of hepatitis C virus, PLoS Pathog, vol.12, issue.5, p.1005610, 2016.